DAWE. National Recovery Plan for the Koala: Phascolarctos Cinereus (combined Populations of Queensland, New South Wales and the Australian Capital Territory) (Department of Agriculture, Water and the Environment, (2022).
Portfolio Committee No. 7. Koala populations and habitat in New South Wales. 1-291. Department of Planning and Environment, New South Wales Goverment, Sydney, New South Wales, (2020).
Hemsley, S. & Canfield, P. Histopathological and immunohistochemical investigation of naturally occurring chlamydial conjunctivitis and urogenital inflammation in Koalas (Phascolarctos cinereus). J. Comp. Pathol. 116, 273–290. https://doi.org/10.1016/S0021-9975(97)80003-5 (1997).
Higgins, D. P., Hemsley, S. & Canfield, P. J. Immuno-histochemical demonstration of the role of Chlamydiaceae in renal, uterine and salpingeal disease of the koala, and demonstration of Chlamydiaceae in novel sites. J. Comp. Pathol. 133, 164–174. https://doi.org/10.1016/j.jcpa.2005.04.005 (2005).
Pagliarani, S., Johnston, S. D., Beagley, K. W., Hulse, L. & Palmieri, C. Chlamydiosis and cystic dilatation of the ovarian bursa in the female Koala (Phascolarctos cinereus): novel insights into the pathogenesis and mechanisms of formation. Theriogenology 189, 280–289. https://doi.org/10.1016/j.theriogenology.2022.06.022 (2022).
Palmieri, C. et al. Chlamydia pecorum infection in the male reproductive system of Koalas (Phascolarctos cinereus). Vet. Pathol. 56, 300–306. https://doi.org/10.1177/0300985818806963 (2019).
Hulse, L. et al. Investigation of pathology associated with Chlamydia pecorum infection in the male reproductive tract, and the effect on spermatogenesis and semen quality in the koala (Phascolarctos cinereus). Theriogenology 180, 30–39 https://doi.org/10.1016/j.theriogenology.2021.12.011 (2022).
Fabijan, J. et al. Chlamydia pecorum prevalence in South Australian Koala (Phascolarctos cinereus) populations: identification and modelling of a population free from infection. Sci. Rep. 9, 6261. https://doi.org/10.1038/s41598-019-42702-z (2019).
Nyari, S. et al. Epidemiology of chlamydial infection and disease in a free-ranging Koala (Phascolarctos cinereus) population. PLoS One. 12, e0190114. https://doi.org/10.1371/journal.pone.0190114 (2017).
Fernandez, C. M. et al. Genetic differences in Chlamydia pecorum between neighbouring sub-populations of Koalas (Phascolarctos cinereus). Vet. Microbiol. 231, 264–270. https://doi.org/10.1016/j.vetmic.2019.02.020 (2019).
Robbins, A., Hanger, J., Jelocnik, M., Quigley, B. L. & Timms, P. Longitudinal study of wild Koalas (Phascolarctos cinereus) reveals chlamydial disease progression in two thirds of infected animals. Sci. Rep. 9, 1–9. https://doi.org/10.1038/s41598-019-49382-9 (2019).
Simpson, S. J. et al. Efficacy of a synthetic peptide Chlamydia pecorum major outer membrane protein vaccine in a wild Koala (Phascolarctos cinereus) population. Sci. Rep. 13, 15087. https://doi.org/10.1038/s41598-023-42296-7 (2023).
Booth, R. & Nyari, S. Clinical comparison of five anti-chlamydial antibiotics in Koalas (Phascolarctos cinereus). PLoS One. 15, e0236758. https://doi.org/10.1371/journal.pone.0236758 (2020).
Govendir, M. et al. Plasma concentrations of Chloramphenicol after subcutaneous administration to Koalas (Phascolarctos cinereus) with chlamydiosis. J. Vet. Pharmacol. Ther. 35, 147–154. https://doi.org/10.1111/j.1365-2885.2011.01307.x (2012).
Dahlhausen, K. E., Doroud, L., Firl, A. J., Polkinghorne, A. & Eisen, J. A. Characterization of shifts of koala (Phascolarctos cinereus) intestinal microbial communities associated with antibiotic treatment. PeerJ 6, e4452 https://doi.org/10.7717/peerj.4452 (2018).
Griffith, J., Higgins, D., Li, K., Krockenberger, M. & Govendir, M. Absorption of Enrofloxacin and Marbofloxacin after oral and subcutaneous administration in diseased Koalas (Phascolarctos cinereus). J. Vet. Pharmacol. Ther. 33, 595–604. https://doi.org/10.1111/j.1365-2885.2010.01169.x (2010).
Desclozeaux, M. et al. Immunization of a wild Koala population with a Recombinant Chlamydia pecorum major outer membrane protein (MOMP) or polymorphic membrane protein (PMP) based vaccine: new insights into immune response, protection and clearance. PLoS One. 12, e0178786. https://doi.org/10.1371/journal.pone.0178786 (2017).
Carey, A. J. et al. A multi-subunit chlamydial vaccine induces antibody and cell-mediated immunity in immunized Koalas (Phascolarctos cinereus): comparison of three different adjuvants. Am. J. Reprod. 63, 161–172. https://doi.org/10.1111/j.1600-0897.2009.00776.x (2010).
Craig, A. P. et al. A 5-year Chlamydia vaccination programme could reverse disease-related Koala population decline: predictions from a mathematical model using field data. Vaccine 32, 4163–4170. https://doi.org/10.1016/j.vaccine.2014.05.049 (2014).
Phillips, S. et al. Immunisation of Koalas against Chlamydia pecorum results in significant protection against chlamydial disease and mortality. Npj Vaccines. 9, 139 https://doi.org/10.1038/s41541-024-00938-5 (2024).
Khan, S. A. et al. Antibody and cytokine responses of Koalas (Phascolarctos cinereus) vaccinated with Recombinant chlamydial major outer membrane protein (MOMP) with two different adjuvants. PLoS One. 11, e0156094. https://doi.org/10.1371/journal.pone.0156094 (2016).
Phillips, S. et al. Vaccination of Koalas during antibiotic treatment for Chlamydia-induced cystitis induces an improved antibody response to Chlamydia pecorum. Sci. Rep. 10, 10152. https://doi.org/10.1038/s41598-020-67208-x (2020).
Khan, S. A. et al. Humoral immune responses in Koalas (Phascolarctos cinereus) either naturally infected with Chlamydia pecorum or following administration of a Recombinant chlamydial major outer membrane protein vaccine. Vaccine 34, 775–782. https://doi.org/10.1016/j.vaccine.2015.12.050 (2016).
Waugh, C. et al. A prototype Recombinant-Protein based Chlamydia pecorum vaccine results in reduced chlamydial burden and less clinical disease in Free-Ranging Koalas (Phascolarctos cinereus). PLoS One. 11, e0146934. https://doi.org/10.1371/journal.pone.0146934 (2016).
Nyari, S., Booth, R., Quigley, B. L., Waugh, C. A. & Timms, P. Therapeutic effect of a Chlamydia pecorum Recombinant major outer membrane protein vaccine on ocular disease in Koalas (Phascolarctos cinereus). PLoS One. 14, e0210245. https://doi.org/10.1371/journal.pone.0210245 (2019).
Waugh, C., Austin, R., Polkinghorne, A. & Timms, P. Treatment of Chlamydia-associated ocular disease via a Recombinant protein based vaccine in the Koala (Phascolarctos cinereus). Biologicals 44, 588–590. https://doi.org/10.1016/j.biologicals.2016.09.006 (2016).
Brown, A. & Grice, R. Experimental transmission of Chlamydia psittaci in the koala. Chlamydial infections. Cambridge University Press, Cambridge, England, 349–352 (1986).
Vitali, S. D., Jakob-Hoff, R. A., Stephenson, R. M., Holz, T. L. & Higgins PH and DP National Koala Disease Risk Analysis Report University of Sydney. https://doi.org/10.25910/xkkv-nk38 (2022).
Lunney, D. et al. Koalas and climate change: a case study on the Liverpool plains, north-west new South Wales. Wildl. Clim. Change: Towards Robust. Conserv. Strategies Australian Fauna. 150–168 https://doi.org/10.7882/FS.2012.022 (2012).
Cleaveland, S., Kaare, M., Tiringa, P., Mlengeya, T. & Barrat, J. A dog rabies vaccination campaign in rural africa: impact on the incidence of dog rabies and human dog-bite injuries. Vaccine 21, 1965–1973. https://doi.org/10.1016/S0264-410X(02)00778-8 (2003).
Belsare, A. V. & Gompper, M. E. To vaccinate or not to vaccinate: lessons learned from an experimental mass vaccination of free-ranging dog populations. Anim. Conserv. 18, 219–227. https://doi.org/10.1111/acv.12162 (2015).
Ferreira, C. et al. Field experimental vaccination campaigns against myxomatosis and their effectiveness in the wild. Vaccine 27, 6998–7002. https://doi.org/10.1016/j.vaccine.2009.09.075 (2009).
Brochier, B., Costy, F. & Pastoret, P. Elimination of Fox rabies from Belgium using a Recombinant vaccinia-rabies vaccine: an update. Vet. Microbiol. 46, 269–279. https://doi.org/10.1016/0378-1135(95)00091-N (1995).
Wandeler, A., Capt, S., Kappeler, A., Hauser, R. & S649-S653. Oral immunization of wildlife against rabies: concept and first field experiments. Rev. Infect. Dis. 10 https://doi.org/10.1093/clinids/10.Supplement_4.S649 (1988).
Close, R., Ward, S. & Phalen, D. A dangerous idea: that Koala densities can be low without the populations being in danger. Aust J. Zool. 38, 272–280. https://doi.org/10.7882/AZ.2015.001 (2017).
Department of Planning and Environment. (Department of Planning and Environement, New South Wales Government Parramatta, (2023).
Kollipara, A. et al. Vaccination of healthy and diseased Koalas (Phascolarctos cinereus) with a Chlamydia pecorum multi-subunit vaccine: evaluation of immunity and pathology. Vaccine 30, 1875–1885. https://doi.org/10.1016/j.vaccine.2011.12.125 (2012).
Fernandez, C. M. et al. Genetic markers of Chlamydia pecorum virulence in ruminants support short term host-pathogen evolutionary relationships in the koala, Phascolarctos cinereus. Infect. Genet. Evol. 116, 105527 https://doi.org/10.1016/j.meegid.2023.105527 (2023).
Khan, S. A. et al. Vaccination of Koalas (Phascolarctos cinereus) with a Recombinant chlamydial major outer membrane protein adjuvanted with Poly I:C, a host defense peptide and Polyphosphazine, elicits strong and long lasting cellular and humoral immune responses. Vaccine 32, 5781–5786. https://doi.org/10.1016/j.vaccine.2014.08.037 (2014).
Lee, T., Zenger, K. R., Close, R. L., Jones, M. & Phalen, D. N. Defining Spatial genetic structure and management units for vulnerable Koala (Phascolarctos cinereus) populations in the Sydney region, Australia. Wildl. Res. 37, 156–165. https://doi.org/10.1071/WR09134 (2010).
R: A language and environment for statistical computing. R Foundation for Statistical Computing, Vienna, Austria, (2022).
Gordon, G. Estimation of the age of the koala, Phascolarctos cinereus (Marsupialia: Phascolarctidae), from tooth wear and growth. Aust Mammal. 14, 5–12. https://doi.org/10.1071/AM91001 (1991).
QGIS Development Team. QGIS Geographic Information System (Version 3.34). (2024). https://doi.org:https://www.qgis.org
Mathew, M., Beagley, K. W., Timms, P. & Polkinghorne, A. Preliminary characterisation of tumor necrosis factor alpha and interleukin-10 responses to Chlamydia pecorum infection in the Koala (Phascolarctos cinereus). PLoS One. 8, e59958. https://doi.org/10.1371/journal.pone.0059958 (2013).
Mathew, M., Waugh, C., Beagley, K. W., Timms, P. & Polkinghorne, A. Interleukin 17A is an immune marker for chlamydial disease severity and pathogenesis in the Koala (Phascolarctos cinereus). Dev. Comp. Immunol. 46, 423–429. https://doi.org/10.1016/j.dci.2014.05.015 (2014).
Mathew, M. et al. Molecular characterisation and expression analysis of Interferon gamma in response to natural Chlamydia infection in the koala, Phascolarctos cinereus. Gene 527, 570–577 https://doi.org/10.1016/j.gene.2013.06.019 (2013).
Dhand, N., Khatkar, M. Statulator An online statistical calculator. Sample Size Calculator for Estimating a Single Proportion (2014).
Columb, M. & Atkinson, M. Statistical analysis: sample size and power estimations. Bja Educ. 16, 159–161 (2016).
Bates, D., Mächler, M., Bolker, B. & Walker, S. Fitting linear mixed-effects models using lme4. arXiv preprint arXiv:1406.5823 (2014).
Christensen, R. H. B. Cumulative Link Models for Ordinal Regression with the R Package ordinal https://cran.uni-muenster.de/web/packages/ordinal/vignettes/clm_article.pdf (2024).
Agresti, A. Categorical Data Analysis. Second Edition (Wiley, 2002).
Madani, G. F., Ashman, K. R., Mella, V. S. A. & Whisson, D. A. A review of the ‘noose and flag’method to capture free-ranging Koalas. Aust Mammal. 42, 341–348. https://doi.org/10.1071/AM19064 (2020).
Griffith, J. E. Studies into the diagnosis, treatment and management of chlamydiosis in koalas PhD thesis, The University of Sydney (2010).
Maher, I. E., Griffith, J. E., Lau, Q., Reeves, T. & Higgins, D. P. Expression profiles of the immune genes CD4, CD8β, IFNγ, IL-4, IL-6 and IL-10 in mitogen-stimulated Koala lymphocytes (Phascolarctos cinereus) by qRT-PCR. PeerJ 2, e280. https://doi.org/10.7717/peerj.280 (2014).
Larkin, R., Palmieri, C., Oishi, M., Hulse, L. & Johnston, S. D. Ultrasonographic assessment of the male Koala (Phascolarctos cinereus) reproductive tract. Res. Vet. Sci. 117, 219–223. https://doi.org/10.1016/j.rvsc.2017.12.019 (2018).
Stalder, K. et al. Sonographic characterisation of the urogenital tract of the Koala (Phascolarctos cinereus) for standardised investigations of urogenital pathology. CVE Control Therapy Ser. 282, 41–48 (2016).
Marschner, C., Flanagan, C., Higgins, D. P. & Krockenberger, M. B. Validation of ultrasonography in detecting structural disease of the urogenital tract of the koala, Phascolarctos cinereus. Aust Vet. J. 92, 177–178. https://doi.org/10.1111/avj.12167 (2014).
Hulse, L. S. et al. Development and application of two multiplex real-time PCR assays for detection and speciation of bacterial pathogens in the Koala. J. Vet. Diagn. 30, 523–529. https://doi.org/10.1177/1040638718770490 (2018).
Ness, R. B. et al. Effectiveness of inpatient and outpatient treatment strategies for women with pelvic inflammatory disease: results from the pelvic inflammatory disease evaluation and clinical health (PEACH) randomized trial. Am. J. Obstet. Gynecol. 186, 929–937. https://doi.org/10.1067/mob.2002.121625 (2002).
Coughlan, C. & Li, T. An update on surgical management of tubal disease and infertility. Obstet. Gynecol. Reproductive Med. 21, 273–280. https://doi.org/10.1016/j.ogrm.2011.07.002 (2011).
Stanberry, L. R. et al. Glycoprotein-D–adjuvant vaccine to prevent genital herpes. N. Engl. J. Med. 347, 1652–1661. https://doi.org/10.1056/NEJMoa011915 (2002).
Wilson, D. P., Craig, A. P., Hanger, J. & Timms, P. The paradox of euthanizing Koalas (Phascolarctos cinereus) to save populations from elimination. J. Wildl. Dis. 51, 833–842 https://doi.org/10.7589/2014-12-278 (2015).
Baker, C., El Hanandeh, A. & Jones, D. Does wildlife crossing infrastructure work? A case study of three canopy-bridge designs and exclusion fencing from Moreton Bay regional council, Queensland. Australian Mammalogy. 45, 108–115 (2022).
Stary, G. et al. A mucosal vaccine against Chlamydia trachomatis generates two waves of protective memory T cells. Science 348, aaa8205. https://doi.org/10.1126/science.aaa8205 (2015).
Agrawal, T. et al. Protective or pathogenic immune response to genital chlamydial infection in women – a possible role of cytokine secretion profile of cervical mucosal cells. Clin. Immunol. 130, 347–354. https://doi.org/10.1016/j.clim.2008.10.004 (2009).
Tuffrey, M., Alexander, F., Conlan, W., Woods, C. & Ward, M. Heterotypic protection of mice against chlamydial salpingitis and colonization of the lower genital tract with a human serovar F isolate of Chlamydia trachomatis by prior immunization with Recombinant serovar L1 major outer-membrane protein. Microbiology 138, 1707–1715. https://doi.org/10.1099/00221287-138-8-1707 (1992).
Schautteet, K. et al. Protection of pigs against Chlamydia trachomatis challenge by administration of a MOMP-based DNA vaccine in the vaginal mucosa. Vaccine 29, 1399–1407. https://doi.org/10.1016/j.vaccine.2010.12.042 (2011).
Morrison, S. G., Su, H., Caldwell, H. D. & Morrison, R. P. Immunity to murine Chlamydia trachomatis genital tract reinfection involves B cells and CD4 + T cells but not CD8 + T cells. Infect. Immun. 68, 6979–6987. https://doi.org/10.1128/iai.68.12.6979-6987.2000 (2000).
Johansson, M., Schön, K., Ward, M. & Lycke, N. Studies in knockout mice reveal that anti-chlamydial protection requires TH1 cells producing IFN-gamma: is this true for humans? Scand. J. Immunol. 46, 546–552. https://doi.org/10.1046/j.1365-3083.1997.d01-167.x (1997).
Caldwell, H. D. & Schachter, J. Antigenic analysis of the major outer membrane protein of Chlamydia spp. Infect. Immun. 35, 1024–1031. https://doi.org/10.1128/iai.35.3.1024-1031.1982 (1982).
Fehlner-Gardiner, C. et al. Molecular basis defining human Chlamydia trachomatis tissue tropism: a possible role for Tryptophan synthase. J. Biol. Chem. 277, 26893–26903. https://doi.org/10.1074/jbc.M203937200 (2002).
Islam, M. M., Jelocnik, M., Huston, W. M., Timms, P. & Polkinghorne, A. Characterization of the in vitro Chlamydia pecorum response to gamma interferon. Infect. Immun. 86, e00714–00717. https://doi.org/10.1128/IAI.00714-17 (2018).
Jelocnik, M. et al. Development and evaluation of rapid novel isothermal amplification assays for important veterinary pathogens: Chlamydia psittaci and Chlamydia pecorum. PeerJ 5, e3799. https://doi.org/10.7717/peerj.3799 (2017).
Ito, J. I. & Lyons, J. M. Role of gamma interferon in controlling murine chlamydial genital tract infection. Infect. Immun. 67, 5518–5521 https://doi.org/10.1128/iai.67.10.5518-5521.1999 (1999).
Cotter, T. W., Ramsey, K. H., Miranpuri, G. S., Poulsen, C. E. & Byrne, G. I. Dissemination of chlamydia trachomatis chronic genital tract infection in gamma interferon gene knockout mice. Infect. Immun. 65, 2145–2152 https://doi.org/10.1128/iai.65.6.2145-2152.1997 (1997).
Caldwell, H. D. et al. Polymorphisms in Chlamydia trachomatis Tryptophan synthase genes differentiate between genital and ocular isolates. J. Clin. Invest. 111, 1757–1769. https://doi.org/10.1172/JCI17993 (2003).
Fahey, J. R. & Olekszak, H. An overview of typical infections of research mice: health monitoring and prevention of infection. Curr. Protocols Mouse Biology. 5, 235–245. https://doi.org/10.1002/9780470942390.mo150023 (2015). https://doi.org:
Vidgen, M. E., Hanger, J. & Timms, P. Microbiota composition of the Koala (Phascolarctos cinereus) ocular and urogenital sites, and their association with Chlamydia infection and disease. Sci. Rep. 7, 5239. https://doi.org/10.1038/s41598-017-05454-2 (2017).
Lewis, M. E. et al. Morphologic and molecular evaluation of Chlamydia trachomatis growth in human endocervix reveals distinct growth patterns. Front. Cell. Infect. Microbiol. 4, 71 https://doi.org/10.3389/fcimb.2014.00071 (2014).
Agrawal, T., Vats, V., Salhan, S. & Mittal, A. Determination of chlamydial load and immune parameters in asymptomatic, symptomatic and infertile women. FEMS Immunol. Med. Microbiol. 55, 250–257 https://doi.org/10.1111/j.1574-695X.2008.00530.x (2009).
Agrawal, T., Vats, V., Wallace, P. K., Salhan, S. & Mittal, A. Cervical cytokine responses in women with primary or recurrent chlamydial infection. J. Interferon Cytokine Res. 27, 221–226. https://doi.org/10.1089/jir.2006.0132 (2007).
Singh, N., Prasad, P., Das, B. & Rastogi, S. Does tumour necrosis factor alpha-induced cyclooxygenase-2 expression lead to spontaneous abortion in Chlamydia trachomatis-infected women. Microb. Pathog. 142, 103994. https://doi.org/10.1016/j.micpath.2020.103994 (2020).
Bobo, L. et al. Evidence for a predominant Proinflammatory conjunctival cytokine response in individuals with trachoma. Infect. Immun. 64, 3273–3279. https://doi.org/10.1128/iai.64.8.3273-3279.1996 (1996).
Öhman, H. et al. IL-10 polymorphism and cell-mediated immune response to Chlamydia trachomatis. Genes Immun. 7, 243–249. https://doi.org/10.1038/sj.gene.6364293 (2006).
Higgins, D. P., Hemsley, S. & Canfield, P. J. Association of uterine and salpingeal fibrosis with chlamydial hsp60 and hsp10 antigen-specific antibodies in Chlamydia-infected Koalas. Clin. Vacc Immunol. 12, 632–639. https://doi.org/10.1128/CDLI.12.5.632-639.2005 (2005).
Murthy, A. K. et al. Tumor necrosis factor alpha production from CD8 + T cells mediates oviduct pathological sequelae following primary genital Chlamydia muridarum infection. Infect. Immun. 79, 2928–2935 https://doi.org/10.1128/iai.05022-11 (2011).
Vlcek, K. R. et al. The contribution of Chlamydia-specific CD8 + T cells to upper genital tract pathology. Immunol. Cell Biol. 94, 208–212 https://doi.org/10.1038/icb.2015.74 (2016).
Igietseme, J. U. et al. Role of T lymphocytes in the pathogenesis of Chlamydia disease. J. Infect. Dis. 200, 926–934. https://doi.org/10.1086/605411 (2009).
Zhou, Z. et al. Characterization of pathogenic CD8 + T cells in Chlamydia-Infected OT1 mice. Infect. Immun. 90, e00453–e00421 https://doi.org/10.1128/IAI.00453-21 (2022).
Brewer, J. M., Conacher, M., Satoskar, A., Bluethmann, H. & Alexander, J. In interleukin-4‐deficient mice, alum not only generates T helper 1 responses equivalent to freund’s complete adjuvant, but continues to induce T helper 2 cytokine production. Euro. J. Immunol. 26, 2062–2066. https://doi.org/10.1002/eji.1830260915 (1996).
Traquina, P., Morandi, M., Contorni, M. & Van Nest, G. MF59 adjuvant enhances the antibody response to Recombinant hepatitis B surface antigen vaccine in primates. J. Infect. Dis. 174, 1168–1175. https://doi.org/10.1093/infdis/174.6.1168 (1996).
